Choice in Medications Improves Patient Outcomes

HALIFAXMay 15, 2014 /CNW/ - InnoviCares, Canada's only free multi-drug manufacturer patient benefit plan, marked their 600,000 member on April 28, 2014, and their participation rates show signs of acceleration through increasing partnerships and widespread patient satisfaction.

"We are extremely pleased with the growth of innoviCares. Since its launch in January 2013, innoviCares has already grown to bring together 18 different drug manufacturers and nearly 100 products covered," said Steve Nicolle, CEO of STI Technologies Ltd, innoviCares parent company. "By complementing public and private drug plans through greater access to original brand name medications, we are improving health outcomes and adherence rates for many patients, and at no additional cost to them."

Employers, associations, physicians, and pharmacists have widely embraced the program, and for countless patients innoviCares offers significant financial savings and stability in their healthcare.

STI Technologies Limited was recently visited by Troy Wellington, an innoviCares member from Barrie, Ontario, who stressed the positive impact that the plan has had in his family's life. "You don't think that something so small could make such a big, drastic change in a person's life, but it did. Emotionally stable, mentally stable, physically stable... The financial burden was lifted from my wife's shoulders for those medications."

InnoviCares supports a patient's choice to remain on original brand name medication by paying towards the cost difference between brand and the generic alternative.

"Reaching out for medical assistance when a person has reasons to believe they may be experiencing mental health concerns is extremely important," says Dave Gallson, Associate National Executive Director for Moods Disorders Society of Canada. "Working with your Doctor or healthcare professional, proper diagnosis and a care plan which often includes finding the appropriate medication can make a significant impact in a patient's continued health and well-being.  Thanks to innoviCares, patients have access to brand medication at the same price of a generic."

To view "Troy's Story" visit:
https://www.youtube.com/watch?v=_n8OmfvIY7I

For more information visit
www.innovicares.ca
www.mooddisorderscanada.ca

SOURCE STI Technologies Limited

Video with caption: "Video: Diagnosed with Bipolar Schizoaffective disorder in 2010, Troy Wellington could no longer afford the out-of-pocket costs for his prescribed medication that had him stabilized, despite facing side effects from the alternate medication covered by his insurance plan. His psychiatrist then introduced him to innoviCares, Canada's only free patient benefit plan, which supports a patient's choice by paying up to the difference between original brand and the generic alternative.". Video available at: http://stream1.newswire.ca/cgi-bin/playback.cgi?file=20140515_C8225_VIDEO_EN_40341.mp4&posterurl=http://photos.newswire.ca/images/20140515_C8225_PHOTO_EN_40341.jpg&clientName=STI%20Technologies%20Limited&caption=Video%3A%20Diagnosed%20with%20Bipolar%20Schizoaffective%20disorder%20in%202010%2C%20Troy%20Wellington%20could%20no%20longer%20afford%20the%20out%2Dof%2Dpocket%20costs%20for%20his%20prescribed%20medication%20that%20had%20him%20stabilized%2C%20despite%20facing%20side%20effects%20from%20the%20alternate%20medication%20covered%20by%20his%20insurance%20plan%2E%20His%20psychiatrist%20then%20introduced%20him%20to%20innoviCares%2C%20Canada%27s%20only%20free%20patient%20benefit%20plan%2C%20which%20supports%20a%20patient%27s%20choice%20by%20paying%20up%20to%20the%20difference%20between%20original%20brand%20and%20the%20generic%20alternative%2E&title=STI%20TECHNOLOGIES%20LIMITED%20%2D%20Free%20Drug%20Benefit%20Plan%20&headline=Free%20Drug%20Benefit%20Plan%20Supports%20Over%20Half%20a%20Million%20Canadians

Image with caption: "Troy & Sheri Wellington were faced with choosing between medical stability and financial stability until InnoviCares, Canada's only free patient benefit plan, paid the difference between the original brand medication and the generic alternative. (CNW Group/STI Technologies Limited)". Image available at:http://photos.newswire.ca/images/download/20140515_C8225_PHOTO_EN_40339.jpg

 For further information:

Erin Solomon, Marketing Associate, STI
Tel: 902-442-2071
This email address is being protected from spambots. You need JavaScript enabled to view it.

About STI Technologies Limited
www.smartsti.com

The corporate STI Technologies Limited Privacy Policy has been updated as of today. These updates will go into effect immediately.

STI Technologies Limited respects your concerns about privacy and takes the protection of information very seriously. That commitment to our users hasn’t changed.

Here is a quick overview of the changes:

  • To assist you in making an informed decision when using our site and services, we’ve rewritten our policy with clearer language.
  • We’ve added a Customer Service section. In a nutshell, it means that if you contact our customer service team, we will retain some basic information, for example, your name and phone number, so we can better serve you should you reach out again.  
  • To reflect how we may use content for marketing (or other) purposes, we've added a Social Media and Website section.
  • In addition, we’re including a section on Google Analytics, which we will use to monitor our website’s traffic. (Learn more about Google Analytics.)

 

We don’t sell your personal information to third parties and we comply with all Canadian federal and provincial privacy laws.

If you have any questions about these updates, please contact us at 1-877-790-1991 or email This email address is being protected from spambots. You need JavaScript enabled to view it.

Anticipating Growth at Homegrown Health-Care IT Company, STI

Nova Scotia Business Inc.

March 7, 2014 - STI provides over a million patients in Canada with more choice in their medications and is now looking to expand even more.

From a three-person start-up company, to helping millions of patients save money on their brand name prescriptions, STI Technologies Inc. is a local company providing comprehensive technology and solutions that benefit patients, doctors, pharmacies and drug manufacturers across Canada. 

"The talent in Nova Scotia is world class and we've built our success on creating numerous challenging and rewarding career opportunities for both those who wish to remain in the region, as well as those who want to come and live here," said Steve Nicolle, chief executive officer, STI Technologies Limited.

STI is gearing up to expand and has signed a five-year incentive agreement with Nova Scotia Business Inc. (NSBI) to encourage the company's investment and employment choices to happen in Nova Scotia. 

To start, STI must create at least seven full-time equivalent positions in the first year of the agreement. Once that happens, the company is eligible to earn a rebate on the payroll it spent creating the new positions. This rebate applies to new positions between the minimum of seven and maximum of 48. 

STI will add over $9 million in salary costs if the company creates 48 new positions. Employees would then pay provincial personal income taxes of about $1.13 million. As a result, the company can earn up to $669,320 in payroll rebates through NSBI's Strategic Investment Funds. 

"Our market is the Canadian pharmaceutical industry, which is concentrated in Toronto and Montreal. This NSBI payroll rebate will allow us to continue to add even more jobs here in Halifax and overcome some of the challenges that represents to our competitive situation," said Mr. Nicolle.

The venture-backed company currently employs more than 50 people, including software engineers, sales and marketing professionals, and a variety of other head-office personnel. STI's unique business approach has been successful in attracting professionals to Nova Scotia to live and work, in addition to hiring an equal number of new graduates of Nova Scotia universities; making up over 40 per cent of their current workforce. 

"STI is a tremendous example of home-grown entrepreneurship, with the majority of its leadership team having Dalhousie heritage", said Ed Leach, assistant professor and director of the Norman Newman Centre for Entrepreneurship, Rowe School of Business, Dalhousie University. "The region needs more companies like STI with a proven track record of cultivating a new generation of entrepreneurs, by providing rewarding job opportunities here in Atlantic Canada for our co-op students and graduates in business, computer science, and health sciences."

STI offers intelligent reimbursement programs that help patients save money on many prescription medications. STI's programs broaden access and choice to medications and healthcare products for all Canadians, making them a leader in the healthcare industry. 

For more information on STI and new job opportunities, visit www.smartsti.com or email the company directly at This email address is being protected from spambots. You need JavaScript enabled to view it. .

innoviCares launches app to help improve patient choice and health outcomes

HALIFAX, Dec. 3, 2013 - STI, the leader in intelligent reimbursement solutions for the Canadian healthcare market, releases the innoviCares app, designed to promote personal healthcare management and improve adherence to prescribed medications, available at the iTunes store for all registered innoviCares members.

InnoviCares offers additional coverage for many original brand name medications and healthcare products and is provided to patients at no cost by STI, in partnership with participating pharmaceutical manufacturers. For many of the participating products, innoviCares provides members the choice to stay on original brand name medications. The newly released iPhone app gives members a digital version of their card and provides them with useful features, like easily actionable prescription refill alerts.   These reminders are based on real intelligence driven from prescription possession data.

"Our hope is that Canadians take prompt and proper action when managing their healthcare. Adherence to prescribed medications equals better patient outcomes and reduced overall costs.  The innoviCares iPhone app is a simple tool that can assist patients in this regard." says Dave Gallson, Associate National Executive Director for the Mood Disorders Society of Canada.

In addition to the adherence alerts, other notable features include a pharmacy locator that maps the nearest preferred pharmacy who can serve the patient best, personalized benefits and savings, and an up-to-date list of what products are covered on the card.  Patients simply bring their innoviCares card to their pharmacy when filling a prescription and the card works similar to their drug insurance card, providing coverage on participating products.

"I have a chronic condition that requires frequent prescription refills that I use my innoviCares card to save a substantial cost difference for," says Michel Roy, a Quebec patient. "Knowing what pharmacies are going to serve me best is invaluable."

The innoviCares program was launched early this year, showing great early traction with over 400,000 members using the program across Canada. There are currently over 55 different products covered on the program, including diabetes products, chronic pain medications and cancer drugs, along with dozens of other original brand name medications such as Imovane, Wellbutrin XL, Crestor, Nexium, Pantoloc, and Altace. This program is provided at no cost and patients can get a card by visiting www.innovicares.ca. The innoviCares app is currently available to innoviCares members for the iPhone and can be downloaded from the iTunes store.

STI was featured in The Globe & Mail's Special Report on The Future of Prescription Drugs with a full page ad and page of editorial content on patient choice and innoviCares. The editorial includes interviews with patients, physicians, patient advocates and STI's CEO, Steve Nicolle. The ad and article are part of the 8 page Special Report which is included in every Globe & Mail newspaper across Canada. To view the PDF of the article, Click Here.

 

Page 1 of 7

plavix.jpg